Published in J Gen Intern Med on April 02, 2008
Scholarship opportunities for trainees and clinician educators: learning outcomes from a case report writing workshop. J Gen Intern Med (2008) 1.40
Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review. J Clin Endocrinol Metab (2015) 0.88
Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2003) 3.33
Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab (2005) 3.32
Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg (2003) 2.88
The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab (2005) 2.80
Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg (2001) 1.64
Carcinoid tumors. Am Fam Physician (2006) 1.58
Hepatic surgery for metastases from neuroendocrine tumors. Surg Oncol Clin N Am (2003) 1.48
Cushing's syndrome--killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet (1982) 1.45
Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases. Ann N Y Acad Sci (2002) 1.42
Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag (2005) 1.32
Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumors. Pancreas (2005) 1.27
Evaluation and treatment of Cushing's syndrome. Am J Med (2005) 1.19
Long-term outcome of bilateral adrenalectomy in patients with Cushing's syndrome. Surgery (1994) 1.05
Differential diagnosis and imaging in Cushing's syndrome. Endocrinol Metab Clin North Am (2005) 1.00
Primary hepatic carcinoid tumor presenting as Cushing's syndrome. J Endocrinol Invest (2007) 0.97
Outcome of adrenalectomy for Cushing's syndrome: experience from a tertiary care center. World J Surg (2007) 0.97
Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases. World J Surg (2001) 0.94
Cushing's disease: clinical manifestations and diagnostic evaluation. Am Fam Physician (2000) 0.78
Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Clin Cancer Res (2013) 2.00
Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor. Cell Res (2006) 1.51
Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy. BMC Cancer (2008) 1.05
Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients. J Clin Endocrinol Metab (2006) 1.05
Update on options for treatment of metastatic castration-resistant prostate cancer. Onco Targets Ther (2010) 1.00
Phase II trial of dolastatin-10 in patients with advanced breast cancer. Invest New Drugs (2005) 0.97
The role of mammography in male patients with breast symptoms. Mayo Clin Proc (2007) 0.93
Quality of life of men with biochemical recurrence of prostate cancer. J Psychosoc Oncol (2008) 0.91
Current therapeutic strategies for invasive and metastatic bladder cancer. Onco Targets Ther (2011) 0.90
Pheochromocytoma producing vasoactive intestinal peptide. Mayo Clin Proc (2002) 0.86
Quality of life of patients undergoing surgical treatment for newly-diagnosed, clinically localized renal cell carcinoma. J Psychosoc Oncol (2011) 0.84
Sorafenib-induced pancreatitis. Mayo Clin Proc (2007) 0.81
Treatment of men with rising prostate-specific antigen levels following radical prostatectomy. Expert Rev Anticancer Ther (2011) 0.80
Balloon kyphoplasty for vertebral compression fractures secondary to polyostotic fibrous dysplasia. Case report. J Neurosurg Spine (2005) 0.77
Editorial comment. Urology (2010) 0.75
Medical image. papules of unknown aetiology. Disseminated Curvularia. N Z Med J (2012) 0.75
The management of bone loss in patients with breast or prostate cancer. Support Cancer Ther (2004) 0.75
A pilot investigation of a multidisciplinary quality of life intervention for men with biochemical recurrence of prostate cancer. Psychooncology (2010) 0.75